Antares Vision (AV) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
13 Jun, 2025Executive summary
9M 2024 results show improved margins and profitability despite a 10.9% year-over-year revenue decline, mainly due to weak U.S. market performance.
Strong growth in Italy (+27%) and Europe (+32%), and Services BU (+11%) partially offset revenue declines in the Americas (-22%).
New orders increased 6% year-over-year, driven by Italy, Europe, FMCG (+8%), and Life Science & Cosmetics (+7%).
Recurring revenues (Services and SCT) grew 5% and now represent 46% of total revenues, up from 39% in 9M 2023.
Operating cash flow exceeded €40M in 9M 2024, maintaining robust cash generation.
Financial highlights
9M 2024 consolidated revenues were €127.9M, down 10.9% year-over-year; on a like-for-like basis, revenues fell 5.6%.
Recurring revenues (Services + SCT) now represent 46% of total revenues, up from 39% in 9M 2023.
Europe, including Italy, accounted for 52% of sales, up from 45% in 9M 2023.
Americas' share of sales dropped to 37% from 43% in 9M 2023, reflecting a 22% revenue decline.
Italian revenues rose 27% year-over-year.
Outlook and guidance
FY 2024 guidance confirmed: revenue growth of 4–6% on a like-for-like basis, starting from a €204M FY 2023 base.
Adjusted EBITDA margin expected at the higher end of the 11.5–14% range.
Net Debt/EBITDA targeted at the lower end of the 4.1–3.3x range, supported by strong operating cash flow.
Revenues expected to rebound sharply in 4Q 2024.
Latest events from Antares Vision
- FY 2025 revenues fell 2% to €204M, with SCT and recurring revenue growth offsetting Life Science weakness.AV
Q4 202513 Feb 2026 - 9M 2025 revenues up 5% to €134M; FY outlook flat with lower EBITDA margin expected.AV
Q3 202514 Nov 2025 - Orders up 14%, revenues rose 3.3%, EBITDA doubled, and net loss narrowed in 1H 2025.AV
Q2 202512 Sep 2025 - Adjusted EBITDA rebounded to €3.4M as recurring business and margins improved.AV
Q2 202413 Jun 2025 - 2024-2026 plan aims for strong revenue and EBITDA growth, driven by innovation and efficiency.AV
Strategy Update13 Jun 2025 - Q1 2025 orders up 25% year-over-year, with recurring revenues at 49% of total.AV
Q1 20256 Jun 2025 - Profitability and cash flow surged, with recurring revenues and leverage improving.AV
H2 20246 Jun 2025 - Strong 4Q drives revenue, margin, and order growth, setting up a positive 2025 outlook.AV
Q4 20246 Jun 2025